The DOI matches its Crossref record; 39 of the 41 references it cites were found in a registry or an index.
The role of TNFα and TNF receptors in obesity and insulin resistance
Open accessAbstract
Abstract. Hotamisligil GS (Harvard University, Boston, Massachusetts, USA). The role of TNFα and TNF receptors in obesity and insulin resistance. (Minisymposium: Genes & Obesity). J Intern Med 1999; 245: 621–625. Insulin resistance, a smaller than expected response to a given dose of insulin, is associated with many common diseases including, ageing, polycystic ovarian disease, syndrome X, cancer, infections, trauma and, most significantly, obesity and type 2 diabetes mellitus. The biochemical basis of insulin resistance in type 2 diabetes has been the subject of many studies. Earlier studies have indicated that quantitative regulation of the insulin sensitive glucose transporters (Glut‐4) and insulin receptors themselves may contribute to this disorder, however, these two factors are probably inadequate to explain the extent of insulin resistance. This point also became apparent by the development of only mild hyperinsulinaemia in mice with a targeted mutation in the Glut‐4 gene. Studies on postreceptor defects in type 2 diabetes has recently focused on the intrinsic catalytic activity of the insulin receptor and downstream signalling events. A reduction in tyrosine phosphorylation of both the insulin receptor (IR) and the insulin receptor substrate‐1 (IRS‐1) has been noted in both animal and human type 2 diabetes. Importantly, this appears to occur in all of the major insulin‐sensitive tissues, namely the muscle, fat and liver. It is now clear that decreased signalling capacity of the insulin receptor is an important component of this disease. I will review some of the potential mechanisms underlying this deficiency.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TNF␣ is an important factor contributing to obesity-related insulin resistance (46).”
From Expression of Mfn2, the Charcot-Marie-Tooth Neuropathy Type 2A Gene, in Human Skeletal Muscle (2005) · cites this paper as [46]
In the citing paper
“Evidence indicates that inflammation causes insulin resistance”
From Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty (2018) · cites this paper as [283]
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Protection from obesity-induced insulin resistance in mice lacking TNF-α function
Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. (1997) · Nature · doi:10.1038/39335 · Cited by 2,234
Self-citationRole of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
Kern, P. A., Saghizadeh, M., Ong, J. M., Bosch, R. J., Deem, R., & Simsolo, R. B. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117899 · Cited by 1,305
Tumor necrosis factor alpha inhibits signaling from the insulin receptor.
Hotamışlıgil, G. S., Murray, D. L., Choy, L., & Spiegelman, B. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4854 · Cited by 1,220
Hotamışlıgil, G. S., Johnson, R. S., Distel, R. J., Ellis, R., Papaioannou, V. E., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.274.5291.1377 · Cited by 915
Hotamisligil, G. S., Budavari, A., Murray, D., & Spiegelman, B. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117495 · Cited by 819
The expression of TNF alpha by human muscle. Relationship to insulin resistance.
Saghizadeh, M., Ong, J. M., Garvey, W. T., Henry, R. R., & Kern, P. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118504 · Cited by 717
Cited by
Sorted by citations
Items 701–783 of 783
EFAs/PUFAs and Their Metabolites in Insulin Resistance
Das, U. N. (2010) · Wiley eBooks · doi:10.1002/9780813820637.ch19
Tumor necrosis factor (TNF) inhibition in the treatment of vasculitis
Stone, J. H. (2001) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8235-4_3
¿Debemos incluir la determinación de la resistina en la práctica clínica?
Rubio, M. Á. (2003) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(03)74503-3
Glucose Intolerance Modifies the Inflammatory Response After Intestinal Ischemia‐Reperfusion
Pérez, J. C. G., Arias‐Díaz, J., Vara, E., & Balibrea, J. L. (2005) · World Journal of Surgery · doi:10.1007/s00268-005-7700-9
Health and Disease as Two Sides of the Same Coin
Das, U. N. (2011) · Springer eBooks · doi:10.1007/978-94-007-0495-4_2
Nature and mechanisms of insulin resistance - role of adipokines in etiology and pathogenesis.
Slavov, E. (2009) · Trakia Journal of Sciences
Siefers, K., Wegman‐Points, L., Witmer, J. R., & Pierce, G. L. (2014) · The FASEB Journal · doi:10.1096/fasebj.28.1_supplement.lb706
INFLAMMATION IN DIABETIC WOMEN WITH CARDIOVASCULAR DISEASE
Tuttle, H. A. (2003) · UA Campus Repository (The University of Arizona)
Güçlü, M., Kaderli, B., & Ersoy, C. (2015) · Medicine Science | International Medical Journal · doi:10.5455/medscience.2015.04.8253
Metabolic Syndrome X and low-grade systemic inflammation
Das, U. N. (2002) · Springer eBooks · doi:10.1007/978-1-4419-8564-4_6
Metabolic syndrome: a disease of the brain
Singh, R., Fabien, D. M., & Wilczynska, A. (2010) · Journal of Clinical & Experimental Dermatology Research
The Role of Polymorphism of Adiponectin Gene in the Atherosclerosis
Cho, Y.-W., & Kim, S. (2005) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2005.20.1.8
EFFECT OF ASPIRIN PRETREATMENT IN STREPTOZOTOCINE INDUCED TYPE-II DIABETIC RATS
Martha, S., Devarakonda, K. R., Reddy, A. R. N., & Pantam, N. (2008)
Adiponectin in Relation to Glucose and Insulin Resistance in Asthma Patients
Khorshidi, D., & Ma, S. (2011)
InCHIANTI study Sarcopenic obesity and inflammation in the
Bandinelli, S., Lauretani, F., Ferrucci, L., Schrager, M. A., Metter, E. J., Simonsick, E. M., Blè, A., Hubbard, J. M., Cohen, H. J., Muss, H. B., et al. (2015)
Insulin action on large artery stiffness in normal and insulin resistant subjects
Westerbacka, J. (2001) · Työväentutkimus Vuosikirja
Retinoic acid in adipocyte biology
Berry, D. C. (2011) · OhioLink ETD Center (Ohio Library and Information Network)
Biochemical and molecular targets of novel antidiabetic agents
Singh, A. B. (2009) · INFLIBNET
THE ROLE OF DIETARY FAT AND CARBOHYDRATES IN DEVELOPMENT OF ADIPOSE TISSUE INFLAMMATION
Ngo, H. T. (2009) · NORA - Norwegian Open Research Archives
Adiponectin and Atherosclerosis
Khandouzi, M. (2013) · IOSR Journal of Pharmacy and Biological Sciences · doi:10.9790/3008-0853235
Begum, A. N., Chitraa, C., & Nirmala Devi, K. (2015) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2015/119
김태경, 조진경, 정정욱, & Kang, H. (2009) · Exercise Science · doi:10.15857/ksep.2009.18.1.21
Sadia, B. (2013) · HEC National Digital Library
Role of IGF-I in aspirin pretreatment in streptozotocin induced type-II diabetic rats
(2009) · The Internet Journal of Pharmacology · doi:10.5580/74
Childhood obesity, nutrition and metabolic health
Goran, M. I., Cruz, M. L., Shaibi, G. Q., Weigensberg, M. J., Spruijt‐Metz, D., Ebbeling, C. B., & Ludwig, D. S. (2005) · Elsevier eBooks · doi:10.1533/9781845690540.1.86
Obesity, Polycystic Ovary Syndrome, and Mood Disorders
Reynolds-May, M. F., & Rasgon, N. (2006) · Medical psychiatry · doi:10.3109/9780849374517.009
Physiology, pathophysiology, and aging
Berlin, A. L. (2011) · CRC Press eBooks · doi:10.3109/9781841848792-5
糖尿病 診断から自己管理まで I. 診断と病態 3. 糖尿病の病態 インスリンの分泌障害か抵抗性か 2) 抵抗性
Ogawa, W. (2000) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.89.1512
Kiràly, M. A. (2008) · TSpace (University of Toronto)
Bustamante-Zuluaga, C., Vergara-Quintero, F., & Díaz-Yúnez, I. (2013)
Oswal, D. P. (2014) · CORE Scholar (Wright State University)
ADIPOSIDAD, ESTADO PRO-INFLAMATORIO Y RESISTENCIA A LA INSULINA DURANTE LA
Barrios, M., & Carías, D. (2012)
Effects of pro-inflammatory cytokines on central actions of leptin and insulin
Allister, E. M. (2014) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-a-010262596
Hepatitis C–Associated Diabetes Mellitus
Bilić-Čurčić, I., Roguljić, H., Ivandić, M., Včev, A., Smolić, R., & Smolić, M. (2017) · InTech eBooks · doi:10.5772/intechopen.70721
Obesogens and Nuclear Receptors
GÖNEY, G. (2017) · Journal of Applied Biotechnology & Bioengineering · doi:10.15406/jabb.2017.04.00098
Xu, E. (2012) · Corpus Université Laval (Université Laval)
Mélançon, S. (2005) · Corpus Université Laval (Université Laval)
Emerging therapeutic approaches
McLean, G. R., Girkin, J. L. N., & Solari, R. C. E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816417-4.00009-3
Measurement of pathologically relevant adipocyte-derived extracellular vesicles
Mathew, D. (2019) · ORCA Online Research @Cardiff (Cardiff University)
Khan, M. J. (2011) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Frendo‐Cumbo, S. (2021) · TSpace (University of Toronto)
The Relationship Between the Insulin Receptor Substrates and Metabolic Disease
White, M. F. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-116-5_14
Endothelial dysfunction in insulin resistance : the role of EDHF and gap junction communication
Young, E. J. (2010) · RMIT Research Repository (RMIT University Library) · doi:10.25439/rmt.27354102
Physiology, pathophysiology and aging
(2011) · CRC Press eBooks · doi:10.3109/9781841848792-3
(2018) · Wiley eBooks · doi:10.1002/9781118829875.refs
Physiology, pathophysiology, and aging
Berlin, A. L. (2011) · Series in cosmetic and laser therapy · doi:10.3109/9781841848792.002
Childhood obesity, nutrition and metabolic health
Goran, M. I., Cruz, M., Shaibi, G. Q., Weigensberg, M. J., Spruijt‐Metz, D., Ebbeling, C. A., & Ludwig, D. S. (2010) · Woodhead Publishing Limited eBooks · doi:10.1533/9781845690840.1.86
(2005) · Wiley eBooks · doi:10.1002/9780470774663.refs
The Liver and Insulin Resistance: The Important Convergence of Endocrinology and Hepatology
Chang, C., Whitt, K. N., Liu, Z., & Caldwell, S. H. (2019) · Contemporary Endocrinology · doi:10.1007/978-3-030-25057-7_13
IMMORTALIZATION OF HUMAN HEPATOCYTES BY TEMPERATURE-SENSITIVE SV40 LARGE-T ANTIGEN
Smalley, M. J., Leiper, K. A., Tootle, R., McCloskey, P., O'Hare, M. J., & Hodgson, H. J. F. (2001) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1290/1071-2690(2001)037 · Cited by 21
Semaphorin 4B is an ADAM17-cleaved inhibitor of adipocyte thermogenesisPreprint
Amin, A., Badenes, M., Tüshaus, J., de Carvalho, É., Burbridge, E., Faísca, P., Trávníčková, K., Barros, A., Carobbio, S., Domingos, P. M. D. N., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.11.511765
Zukhi, J., Suhaimi, F. M., Mazlan, M. Z., Muhammad, F., Sopian, M. M., Jamaludin, U. K., & Razak, N. N. A. (2023) · International Conference on Health Science and Technology (ICHST) · doi:10.1109/ichst59286.2023.10565326
Myers, C. (2024) · Springer eBooks · doi:10.1007/978-3-031-47065-3_2
冯, 海. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.1541123
Сергеевич, П. Е., Борщев, Ю. Ю., & Galagudza, M. M. (2025) · University therapeutic journal · doi:10.56871/utj.2025.49.77.004
Jung, S. (2025) · Physical Activity and Nutrition · doi:10.20463/pan.2025.0010
Xu, Y., Wang, G., Wang, W., Jia, J., Gao, Q., Xu, H., Zhu, A., Zhao, J., Zhang, Y., Liu, Z., et al. (2025) · BMC Veterinary Research · doi:10.1186/s12917-025-04988-2
Inflammation and Metabolic Syndrome
Ikonomova, K. (2022) · DOAJ (DOAJ: Directory of Open Access Journals)
Ferrer, B. (2013) · TDX (Tesis Doctorals en Xarxa)
Udahogora, M. (2012) · University Libraries (University of Maryland)
Puberty, Insulin Resistance, and Type 2 Diabetes
Goran, M. I., & Sothern, M. S. (2016) · CRC Press eBooks · doi:10.1201/9781420026634-15
Yan, F., Chen, X., Quan, X., Wang, L., Wei, X., & Zhu, J. (2024) · Figshare · doi:10.6084/m9.figshare.25792869
Yan, F., Chen, X., Quan, X., Wang, L., Wei, X., & Zhu, J. (2024) · Figshare · doi:10.6084/m9.figshare.25792760
Ghosh, S. (2020) · Figshare · doi:10.25417/uic.12481091 · Cited by 1
Guo, D., Shi, Z., Luo, Y., Ding, R., & He, P. (2024) · Figshare · doi:10.6084/m9.figshare.26568505
Yan, F., Chen, X., Quan, X., Wang, L., Wei, X., & Zhu, J. (2024) · Figshare · doi:10.6084/m9.figshare.26718375
Yan, F., Chen, X., Quan, X., Wang, L., Wei, X., & Zhu, J. (2024) · Figshare · doi:10.6084/m9.figshare.26718381
Yan, F., Chen, X., Quan, X., Wang, L., Wei, X., & Zhu, J. (2024) · Figshare · doi:10.6084/m9.figshare.26718378
Nogues, P. (2019) · theses.fr (ABES) · doi:10.70675/c3ecfee5ze428z4395za563za025758f71a2
Hong, S., Kohn, J. N., Dimitrov, S., Pruitt, C. S., Cheng, T., & Shaikh, F. (2026) · NeuroImmunoModulation · doi:10.1159/000552352
Peng, K., Zhang, X., Lu, M., Zhu, H. X., Song, X., Lao, J., Wang, W., Tang, G., Ma, J., Li, J., et al. (2026) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2026.112813
吕, 晓. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1662363
Regulation of Mitochondrial Fuel Handling by the Peroxisome Proliferator-Activated Receptors
Sugden, M. C., & Holness, M. J. (2007) · Springer eBooks · doi:10.1007/978-0-387-69945-5_3
Metadata
- Authors
- Hotamisligil, G. S.
- Venue
- Journal of Internal Medicine
- Publisher
- Wiley
- Published
- 1999-06
- Volume
- 245
- Issue
- 6
- Pages
- 621-625
- ISSN
- 0954-6820 (ISSN-L)
- 1365-2796
- OpenAlex
- W2009818179
- Cited by
- 780
- References
- 41
- Citations by year
- 2026: 5 · 2025: 14 · 2024: 13 · 2023: 9 · 2022: 15 · 2021: 24 · 2020: 7 · 2019: 16 · 2018: 23 · 2017: 25 · 2016: 24 · 2015: 19 · 2014: 25 · 2013: 34 · 2012: 31
- FWCI
- 6.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- TNF-α, TNF receptor, obesity, insulin resistance, type 2 diabetes, insulin receptor signaling, tyrosine phosphorylation, IRS-1, GLUT4, postreceptor defect
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Mice, Transgenic, Obesity, Tumor Necrosis Factor-alpha, Receptors, Tumor Necrosis Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review